Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold

Top Stories

Mumbai - AstraZeneca said it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant.

By Reuters

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Thu 10 Sep 2020, 2:13 PM

Last updated: Thu 10 Sep 2020, 4:33 PM

Serum Institute of India has put trials of AstraZeneca's Covid-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday.
"We are reviewing the situation and pausing India trials," Serum said in a brief statement.
AstraZeneca said on Tuesday it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant, but its partner Serum had at the time said its trials in India were still ongoing.


More news from